Medicare opens to ages 50–64; feds to negotiate drug prices
H.R. 7909 — Medicare Expansion and Lowering Costs Now Act · Filed by Raja Krishnamoorthi (D-IL) · Introduced Mar 12, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare to allow people aged 50–64 to buy into the program, adds a new direct supplemental insurance option to cover cost-sharing, authorizes the federal government to negotiate drug prices with pharmaceutical manufacturers on behalf of Medicare beneficiaries, establishes a reinsurance fund to stabilize individual health insurance markets, and increases the income threshold for premium tax credits under the Affordable Care Act. The bill aims to lower out-of-pocket costs and expand coverage for hearing, dental, and vision care.
Why we flagged it
The bill's core mechanism is a three-part public health expansion: (1) a Medicare buy-in for ages 50–64, (2) federal drug price negotiation, and (3) individual market stabilization through reinsurance. These are substantive policy changes, not commemorative or procedural.
- Section 10 amends IRC §36B to increase premium tax credit eligibility above 400% of poverty line and restructure applicable percentages. Substantively unrelated to Medicare buy-in or drug negotiation; appears to be a separate ACA affordability measure bundled into the bill.
What the text implies
- The Medicare buy-in premium is set to be budget-neutral (expenditures not increased by reason of this section), meaning premiums may be higher than traditional Medicare to offset federal costs. Enrollees aged 50–64 may face higher premiums than they expect if adverse selection occurs.
- The reinsurance fund (Section 6) is funded by fees on qualified health plans participating in the program, creating a cost-shifting mechanism: insurers pass fees to enrollees in the individual market, potentially offsetting premium reductions for some groups.
The full analysis lists 5 implications of this text.
Who stands to gain
Medicare beneficiaries aged 50–64 (lower premiums and expanded coverage); Lower-income individuals (expanded premium tax credits); Health insurance issuers in individual market (reinsurance payments for high-cost enrollees)